PP

Pooja Prasad Kulkarni

Active Director Designated Partner DIN 10024426
DIN 10024426 First appointment Oct 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pooja Prasad Kulkarni

Data last updated:

Pooja Prasad Kulkarni is a Designated Partner at Mapchem Pharma Llp (since 2022). The company operates in Pharma.

DIN 10024426
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Oct 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Oct 20222022Active

Board colleagues of Pooja Prasad Kulkarni

NameDINCompanyDesignation
Ashish Mithalal Sethia01428188Mapchem Pharma LlpDesignated Partner
Palash Pradeep Kavediya10455290Mapchem Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mapchem Pharma Llp
Premium access

Shareholding and investment profile for Pooja Prasad Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pooja Prasad Kulkarni

Pooja Prasad Kulkarni currently holds 1 directorship: Mapchem Pharma Llp (Designated Partner, since 17 Oct 2022).

Pooja Prasad Kulkarni was first appointed on 17 Oct 2022 as Designated Partner at Mapchem Pharma Llp.

The current boards of Pooja Prasad Kulkarni's companies include Ashish Mithalal Sethia (Mapchem Pharma Llp), Palash Pradeep Kavediya (Mapchem Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available